Prime-2-CoV Omicron

N/A

Report date: 2023/10/26 17:13:38

Base Information

Drug NamePrime-2-CoV Omicron
Drug Alias NamePrime-2-CoV OmicronPRIME-2-CoV Omicron
ClassificationVaccines > Vaccine type > Multivalent vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEberhard-Karls Universitaet Tuebingen
China Registration ClassN/A

Develop Information

Active CompaniesSperansa Therapeutics GmbHEberhard-Karls Universitaet Tuebingen
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A